← Russell 3000 cross-section

HCA HCA Healthcare, Inc.

Trailing twelve months to 2026-03-31 · as filed 2026-04-29, not restated
Healthcare

Scale

Market cap
$91.7bn
Revenue TTM
$76.4bn
Net income TTM
$6.8bn
Free cash flow
$7.9bn
Composite score
Sector rank
#138

Valuation

P / E
13.5
EV / EBITDA
EV / sales
1.8
FCF yield
8.65%
Earnings yield vs 10-yr
2.68pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
8.9%
EBITDA margin
ROE
-107.8%
ROIC
Revenue growth
6.7%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued) Second Quarter 2026 Operations Summary Revenues increased to $20.230 billion in the second quarter of 2026 from $18.605 billion in the second quarter of 2025. Net income attributable to HCA Healthcare, Inc. totaled $1.699 billion, or $7.62 per diluted share, for the quarter ended June 30, 2026, compared to $1.653 billion, or $6.83 per diluted share, for the quarter ended June 30, 2025. Revenues increased 8.7% on a consolidated basis and 9.3% on a same facility basis for the quarter ended June 30, 2026, compared to the quarter ended June 30, 2025. …HCA Healthcare, Inc., 10-Q, period ended 2026-06-30, filed 2026-07-28

Read the full passage →